| Interactive association of drugs binding to human serum albumin F Yang, Y Zhang, H Liang International journal of molecular sciences 15 (3), 3580-3595, 2014 | 411 | 2014 |
| α− N− heterocyclic thiosemicarbazone Fe (III) complex: Characterization of its antitumor activity and identification of anticancer mechanism Y Gou, J Wang, S Chen, Z Zhang, Y Zhang, W Zhang, F Yang European Journal of Medicinal Chemistry 123, 354-364, 2016 | 84 | 2016 |
| Structural basis and anticancer properties of ruthenium-based drug complexed with human serum albumin Y Zhang, A Ho, J Yue, L Kong, Z Zhou, X Wu, F Yang, H Liang European journal of medicinal chemistry 86, 449-455, 2014 | 73 | 2014 |
| Developing anticancer copper (II) pro-drugs based on the nature of cancer cells and the human serum albumin carrier IIA subdomain Y Gou, J Qi, JP Ajayi, Y Zhang, Z Zhou, X Wu, F Yang, H Liang Molecular Pharmaceutics 12 (10), 3597-3609, 2015 | 72 | 2015 |
| Developing an anticancer copper (II) pro-drug based on the His242 residue of the human serum albumin carrier IIA subdomain J Qi, Y Zhang, Y Gou, Z Zhang, Z Zhou, X Wu, F Yang, H Liang Molecular pharmaceutics 13 (5), 1501-1507, 2016 | 71 | 2016 |
| Enhancing the copper (II) complexes cytotoxicity to cancer cells through bound to human serum albumin Y Gou, Y Zhang, J Qi, Z Zhou, F Yang, H Liang Journal of inorganic biochemistry 144, 47-55, 2015 | 68 | 2015 |
| Developing anticancer ferric prodrugs based on the N-donor residues of human serum albumin carrier IIA subdomain J Qi, Y Gou, Y Zhang, K Yang, S Chen, L Liu, X Wu, T Wang, W Zhang, ... Journal of Medicinal Chemistry 59 (16), 7497-7511, 2016 | 65 | 2016 |
| In vivo epidermal migration requires focal adhesion targeting of ACF7 J Yue, Y Zhang, WG Liang, X Gou, P Lee, H Liu, W Lyu, WJ Tang, ... Nature communications 7 (1), 1-15, 2016 | 57 | 2016 |
| Structural Basis of Non‐Steroidal Anti‐Inflammatory Drug Diclofenac Binding to Human Serum Albumin Y Zhang, P Lee, S Liang, Z Zhou, X Wu, F Yang, H Liang Chemical biology & drug design 86 (5), 1178-1184, 2015 | 50 | 2015 |
| Multidrug delivery systems based on human serum albumin for combination therapy with three anticancer agents J Qi, Y Zhang, Y Gou, P Lee, J Wang, S Chen, Z Zhou, X Wu, F Yang, ... Molecular Pharmaceutics 13 (9), 3098-3105, 2016 | 45 | 2016 |
| ACF7 regulates inflammatory colitis and intestinal wound response by orchestrating tight junction dynamics Y Ma, J Yue, Y Zhang, C Shi, M Odenwald, WG Liang, Q Wei, A Goel, ... Nature communications 8 (1), 1-16, 2017 | 33 | 2017 |
| Human serum albumin-based design of a diflunisal prodrug F Yang, ZY Ma, Y Zhang, GQ Li, M Li, JK Qin, O Lockridge, H Liang European Journal of Pharmaceutics and Biopharmaceutics 84 (3), 549-554, 2013 | 29 | 2013 |
| Design of an anticancer copper (II) prodrug based on the Lys199 residue of the active targeting human serum albumin nanoparticle carrier Y Gou, Y Zhang, Z Zhang, J Wang, Z Zhou, H Liang, F Yang Molecular Pharmaceutics 14 (6), 1861-1873, 2017 | 26 | 2017 |
| Developing an anticancer copper (II) pro-drug based on the nature of cancer cell and human serum albumin carrier IIA subdomain: mouse model of breast cancer Y Gou, Y Zhang, J Qi, S Chen, Z Zhou, X Wu, H Liang, F Yang Oncotarget 7 (41), 67004, 2016 | 22 | 2016 |
| Binding and anticancer properties of plumbagin with human serum albumin Y Gou, Y Zhang, J Qi, L Kong, Z Zhou, S Liang, F Yang, H Liang Chemical biology & drug design 86 (3), 362-369, 2015 | 21 | 2015 |
| Structural insights into the elevator-type transport mechanism of a bacterial ZIP metal transporter Y Zhang, Y Jiang, K Gao, D Sui, P Yu, M Su, GW Wei, J Hu Nature Communications 14 (1), 385, 2023 | 16 | 2023 |
| Evaluation of interactions between platinum-/ruthenium-based anticancer agents and human serum albumin: development of HSA carrier for metal-based drugs Y Gou, Y Zhang, F Yang, H Liang Current pharmaceutical design 21 (14), 1848-1861, 2015 | 14 | 2015 |
| Comparison of binding characterization of two antiviral drugs to human serum albumin M Li, E McAuley, Y Zhang, LL Kong, F Yang, ZP Zhou, XY Wu, H Liang Chemical Biology & Drug Design 83 (5), 576-582, 2014 | 14 | 2014 |
| Design an anticancer copper (II) pro-drug based on the flexible IIA subdomain of human serum albumin Y Zhang, Z Zhang, Y Gou, M Jiang, H Khan, Z Zhou, H Liang, F Yang Journal of Inorganic Biochemistry 172, 1-8, 2017 | 13 | 2017 |
| X‐ray crystallographic and fluorometric analysis of the interactions of rhein to human serum albumin M Li, P Lee, Y Zhang, ZY Ma, F Yang, ZP Zhou, XY Wu, H Liang Chemical Biology & Drug Design 83 (2), 167-173, 2014 | 7 | 2014 |